A Randomized, Double-Blind, Clinical Study to Evaluate the Safety and Efficacy of SpeedGel Rx® in the Symptomatic Treatment of Osteoarthritis in the Interphalangeal Joints.

This study evaluated the efficacy of SpeedGel Rx® for the treatment of Osteoarthritis of the Interphalangeal joints. In a two-week, randomized, double-blind, placebo-controlled, parallel-group trial, SpeedGel Rx® was administered at a dose of four times daily on the treatment hand. Pain was assessed using a 10-point visual analog scale. The reliability of the scale has been demonstrated in multiple studies.

You can download this file from our repository.